Rare Disease

Latest News

syringe and needle | Image credit: Inna Dodor - stock.adobe.com
IQVIA Report Flags Challenges With Biosimilar Access, Savings Throughout Europe

January 10th 2024

IQVIA’s report on the impact biosimilar competition has had on Europe’s health care space identified ongoing challenges with biosimilar access and generating savings, calling for more policies focusing on fostering a sustainable market for years to come.

red blood cells and white blood cells
Samsung Bioepis' Eculizumab Biosimilar Approved in Europe

May 31st 2023

Phase 3 Study of Amgen Biosimilar to Eculizumab Meets Primary End Points
Phase 3 Study of Amgen Biosimilar to Eculizumab Meets Primary End Points

August 24th 2022

Opinion: Biosimilars Can Aid in Post–COVID-19 Health Care Financial Recovery
Opinion: Biosimilars Can Aid in Post–COVID-19 Health Care Financial Recovery

June 19th 2021

Medicines for Europe Panel Targets Waste in Health Care, Need for Education
Medicines for Europe Panel Targets Inefficiencies, Need for Education

May 28th 2021

Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.